Ligand validation:4YL3

PG4: TETRAETHYLENE GLYCOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4YL3_PG4_A_205	12%	87%	0.237	0.766	0.47	0.24	-	-	0	0	100%	1
6VL4_PG4_A_203	99%	86%	0.047	0.987	0.47	0.25	-	-	0	0	100%	1
4YL0_PG4_A_205	30%	87%	0.21	0.872	0.48	0.22	-	-	1	0	100%	1
5K0I_PG4_A_206	25%	85%	0.138	0.853	0.43	0.32	-	-	0	0	54%	1
5TL9_PG4_A_206	18%	84%	0.21	0.796	0.49	0.28	-	-	0	0	100%	1
5T37_PG4_A_206	16%	86%	0.195	0.847	0.42	0.31	-	-	0	0	54%	1
3DUU_PG4_D_115	100%	78%	0.021	0.993	0.48	0.41	-	-	2	0	100%	1
3DUR_PG4_B_112	100%	77%	0.025	0.99	0.47	0.45	-	-	0	0	100%	1
5VTA_PG4_A_806	100%	74%	0.029	0.993	0.59	0.41	-	-	0	0	100%	1
3NKZ_PG4_C_122	100%	61%	0.035	0.992	0.7	0.78	-	-	1	0	100%	1
3DUS_PG4_B_114	100%	85%	0.039	0.984	0.45	0.29	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.